Targeted Therapies in Cancer: : Myth or Reality?

Alberto Mantovani

ISBN 10: 1441925376 / ISBN 13: 9781441925374

Published by Springer New York, Springer US, 2010

About this Item

Druck auf Anfrage Neuware - Printed after ordering - In September 2005 an International Meeting on 'Targeted Therapies in Cancer: Myth or Reality' was held in Milan. This successful Meeting was intended to represent a forum for scientists and clinicians working in cancer drug discovery and therapy to share their reflections and experiences on how the paradigm shift from empiricism to molecular targeted therapies is contributing to the translation of basic knowledge into new therapies for cancer patients. This book collects the contributions given by scientists and clinicians, from Academia and Industry, who participated to this Meeting.We hope that this book contributes to improve our approach to cancer drug discovery and, ultimately, to find new, more efficacious and better tolerated drugs for cancer patients. It provides an overview of diverse approaches ranging from drug discovery to cellular therapy. Although this change in paradigm has been useful, its entry into the clinical arena was associates with unforeseen problems including the emergence of resistance, unexpected side effects and failures. Time is therefore ripe for a critical cultural reflection on the state of the art, prospects and limitations. Ultimately, is targeted therapy in cancer a myth or a reality.

Seller Inventory # 9781441925374

Bibliographic Details

• Title: Targeted Therapies in Cancer: : Myth or Reality?
• Publisher: Springer New York, Springer US
• Publication Date: 2010
• Language: English
• ISBN 10: 1441925376
• ISBN 13: 9781441925374
• Binding: Taschenbuch
• Condition: Neu
• Dimensions: 235W x 155H x 12D millimeters 235 millimeters width by 155 millimeters height by 12 millimeters depth
• Weight: 312 grams

About this title

Synopsis

Every cancer research scientist will need a copy of this text. As billions of dollars are spent every year on research into targeted therapies for cancer, it’s more than ever crucial for the thousands of scientists working in the field to keep right up to date with the cutting edge. This fascinating collection of material goes a long way to helping them do so, featuring as it does contributions to a crucial international meeting in Italy. The meeting provided a forum for scientists and clinicians working in cancer drug discovery and therapy to share their opinions and experiences on the paradigm shift from empiricism to molecular targeted therapies and its effect on the development of new cancer therapies. The text here offers readers an overview of diverse approaches, ranging from drug discovery to cellular therapy. Overall, the book addresses the key question of whether ultimately targeted therapy in cancer will be a myth or a reality.

From the Back Cover

No BCC for this title.